Joanna Horobin

Joanna Horobin

Direktor/Vorstandsmitglied bei KYMERA THERAPEUTICS, INC.

Vermögen: 2 472 $ am 30.04.2024

69 Jahre
Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Joanna Horobin

EinheitArt der EinheitIndustrie
Public Company Biotechnology 38
Extinct Pharmaceuticals: Major 32
Public Company Pharmaceuticals: Major 21
20
Extinct Biotechnology 20
17
Subsidiary Pharmaceuticals: Major 17
15
Non-Profit Organization Other Consumer Services 15
Public Company Biotechnology 14
Unknown 12
Public Company Biotechnology 11
8
Holding Company Miscellaneous Commercial Services 8

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Joanna Horobin

UnternehmenSektorVerknüpfte PersonenHauptposition
Miscellaneous Commercial Services

Stephen Sherwin

William Reardon

Maxine Gowen

Howard H. Pien

John Maraganore

Arlene Morris

Chairman

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

MERCK & CO., INC. Pharmaceuticals: Major

Howard H. Pien

Cameron Durrant

Jan Hendrik Egberts

Laurent Audoly

Donald Nicholson

Bryant Lim

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

Investment Managers

John Maraganore

Bruce Booth

Pamela Esposito

Jeffrey Albers

Donald Nicholson

Nello Mainolfi

Consultant / Advisor

Private Equity Investor

Consultant / Advisor

Private Equity Investor

Consultant / Advisor

Consultant / Advisor

ACERAGEN, INC. Biotechnology

Michael Dougherty

Maxine Gowen

Cristina Csimma

John J. Kirby

Bryant Lim

Chairman

Director/Board Member

Director/Board Member

Director of Finance/CFO

General Counsel

GSK PLC Pharmaceuticals: Major

Maxine Gowen

Howard H. Pien

Cameron Durrant

Tushar Shah

Raman Singh

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Maxine Gowen

Bruce Jacobs

Dennis Podlesak

Steven Bariahtaris

Brian Albarran

Masters Business Admin

Undergraduate Degree

Graduate Degree

Masters Business Admin

Masters Business Admin

PRELUDE THERAPEUTICS INCORPORATED Biotechnology

Julian Baker

Paul Friedman

Kelvin Neu

Victor Sandor

Bryant Lim

Director/Board Member

Chairman

Director/Board Member

Director/Board Member

Director of Finance/CFO

Biotechnology

Stephen Sherwin

Robert Lippe

Ralph Snyderman

Leigh Morgan

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Human Resources Officer

The University of California, San Francisco College/University

Stephen Sherwin

Luke Evnin

Leigh Morgan

Gorjan Hrustanovic

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

INCYTE CORPORATION Pharmaceuticals: Major

Julian Baker

Paul Friedman

Victor Sandor

Bryant Lim

Director/Board Member

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Compliance Officer

Miscellaneous Commercial Services

R. Fletcher

Andrew LaFrence

Yung Ping Yeh

Paul Hansen

Director/Board Member

Director of Finance/CFO

Founder

Director/Board Member

Harvard Medical School College/University

Stephen Sherwin

Paul Friedman

Kelvin Neu

Jan Hendrik Egberts

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Biotechnology

Steve Hall

Bruce Booth

Donald Nicholson

Gorjan Hrustanovic

Director/Board Member

Founder

Chief Executive Officer

Director/Board Member

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Felix Baker

Ellen Chiniara

Paul Friedman

Elena Ridloff

Director/Board Member

General Counsel

Director/Board Member

Investor Relations Contact

BIOGEN INC. Pharmaceuticals: Major

Stephen Sherwin

Seth A. Rudnick

John Maraganore

Michael Kauffman

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

College/University

Ralph Snyderman

Roger Jeffs

Leigh Morgan

Brian Albarran

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Medical/Nursing Services

Stephen Sherwin

Gisela Schwab

Richard Bryce

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Gisela Schwab

Roger Jeffs

Marco Renoldi

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Director/Board Member

Investment Managers

Felix Baker

Julian Baker

Kelvin Neu

Founder

Founder

Portfolio Manager-Equities

Boston College College/University

Carol Schafer

Richard H. Aldrich

John S. Pallies

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Stephen Sherwin

Gisela Schwab

Richard Bryce

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Paul Manning

Russell Schundler

Damian deGoa

Chief Executive Officer

General Counsel

Chief Executive Officer

Miscellaneous Commercial Services

Richard H. Aldrich

Ansbert Gadicke

R. Fletcher

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

DOVA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Roger Jeffs

Paul Manning

Russell Schundler

Director/Board Member

Chairman

Corporate Secretary

Harvard Business School College/University

William Reardon

Bruce Jacobs

Stephen Kraus

Masters Business Admin

Masters Business Admin

Masters Business Admin

Biotechnology

Felix Baker

Julian Baker

Kelvin Neu

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Michael Dougherty

Howard H. Pien

John J. Kirby

Director/Board Member

Director/Board Member

Comptroller/Controller/Auditor

Princeton University College/University

Luke Evnin

Paul Friedman

Kelvin Neu

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

TREVENA, INC. Pharmaceuticals: Major

Michael Dougherty

Maxine Gowen

Ralph Snyderman

Director/Board Member

Founder

Director/Board Member

Investment Managers

Luke Evnin

Ansbert Gadicke

Kim Kamdar

Founder

Founder

Corporate Officer/Principal

College/University

Julian Baker

Ansbert Gadicke

Stephen Bloch

Undergraduate Degree

Corporate Officer/Principal

Graduate Degree

OLD API WIND-DOWN LTD. Pharmaceuticals: Major

Arthur Kirsch

Seth A. Rudnick

Michael Kaseta

Chairman

Director/Board Member

Director of Finance/CFO

Miscellaneous Commercial Services

Roger Jeffs

Paul Manning

Damian deGoa

Director/Board Member

Director/Board Member

Chief Executive Officer

Medical Specialties

Louis J. Arcudi

Alison Lawton

Jeffrey Albers

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Steve Hall

Bruce Booth

Donald Nicholson

Director/Board Member

Chairman

Chief Executive Officer

Biotechnology

Bruce Booth

Donald Nicholson

Chairman

Director/Board Member

University of Pennsylvania College/University

Seth A. Rudnick

Elena Ridloff

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Luke Evnin

William Reardon

Director/Board Member

Director/Board Member

Investment Managers

Bruce Booth

Nello Mainolfi

Private Equity Investor

Consultant / Advisor

King's College London College/University

Alison Lawton

Rohit Batta

Undergraduate Degree

Doctorate Degree

University of Virginia College/University

Seth A. Rudnick

Russell Schundler

Doctorate Degree

Undergraduate Degree

Harvard College College/University

William Reardon

David Johnson

Undergraduate Degree

Graduate Degree

Statistik

International

Vereinigte Staaten 47
Vereinigtes Königreich 3
Kanada 3

Sektoral

Health Technology 27
Consumer Services 13
Commercial Services 7
Finance 6
Health Services 2

Operativ

Director/Board Member 822
Corporate Officer/Principal 268
Independent Dir/Board Member 265
Chairman 152
Chief Executive Officer 94
  1. Börse
  2. Insiders
  3. Joanna Horobin
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT